Development of a test for detection and quantification of melanoma cells in peripheral blood by of tyrosinase mRNA analysis by RT-PCR and the use of a automatic sequence device;Desarrollo de un test para la detección y cuantificación de células de melanoma en sangre periférica mediante el análisis del RNAm de la tirosinasa por RT-PCR y empleo de un secuenciador automático

Actas Dermo-Sifiliograficas

Volumn 90, Issue 9, 1999, Pages 419-431

  Botella Estrada, Rafael ^a   Barona, Juan Sopena ^a   Vázquez, Enrique Nogueira ^a   O Mánez, Dominica Carpio ^a   Jiménez, Onofre Sanmartín ^a   Llinares, Amparo Sevila ^a   Barona, Carlos Guillén ^a  

^a NONE

Author keywords

Melanoma; mRNA; PCR; Peripheral blood; Tyrosinase

Indexed keywords

EID: 0042826518     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35-42.
2. Barth A, Wanek LA, Morton DL. Prognostic factors in 1512 melanoma patients with distant metastases. J Am Coll Surg 1995;181:193-201.
3. Horikoshi T, Ito S, Wakamatsu K, y cols. Evaluation of melanin-related metabolites as a marker of melanoma progression. Cancer 1994;73:629-36.
4. Hirai S, Kageshita T, Kimura T, y cols. Serum levels of s-ICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression. Melanoma Res 1997;7:58-62.
5. Henze G, Dummer R, Joller-Jemelka HI y cols. Serum S-100: a potential marker for disease monitoring in metastatic melanoma. Dermatology 1997;194:208-12.
6. Abraha HD, Fuller LC, Du-Vivier AW y cols. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 1997;137:381-5.
7. Bosserhoff AK, Kaufmann M, Kaluza B, y cols. Melanoma inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997;57:3149-53.
8. Buzaid AC, Sandler AB, Hayden CL, y cols. Neuron-specific enolase as a tumor marker in metastatic melanoma. Am J Clin Oncol 1994;17:430-1.
9. Sirott MN, Bajorin DF, Wong GYC, y cols. Prognostic factors in patients with metastatic malignant melanoma. Cancer 1993;15:3091-8.
10. Kageshita T, Ono T. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. J Invest Dermatol 1993;101:396-9.
11. Schaider H, Rech-Weichselbraun Y, Richtig E, y cols. Circulating adhesion molecules as prognostic factors for cutaneous melanoma. J Am Acad Dermatol 1997;36:209-13.
12. Fitzpatrick TB, y cols. Tyrosinase in human skin: demonstration of its presence and its rol e in human melanin formation. Science 1950;112:223-8.
13. Hearing VJ, Ekel TM. Mamalian tyrosinase: a comparison of tyrosine hydroxilation and melanin formation. Biochem J 1976;157:549-55.
14. Bouchard B, Fuller BB, Vijayasaradhi S y cols. Induction of pigmentation in mouse fibroblasts by espression of human tyrosinase cDNA. J Exp Med 1989;10:2029-42.
15. Beermann F, Schmid E, Schutz G. Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc Natl Acad Sci USA 1992;89:2809-13.
16. Haninec P, Vachtenheim J. Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes. Pigment Cell Res 1988;1:340-3.
17. Smith B, Selby P, Southgate J, y cols. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-9.
18. Brossart P, Keiholz U, Willhauck M y cols. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993;101:887-9.
19. Hoon D, Wang Y, Dale P, y cols. Detection of occult melanoma cells in blood with a multiple marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-16.
20. Mellado B, Colomer D, Castel T, y cols. Detection of circulating neoplastic cells by reverse transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996;14:2091-7.
21. Battayani Z, Grob J, Xerri L, y cols. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995;131:443-7.
22. Foss A, Guille M, Occleston N. y cols. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 1995;72:155-9.
23. Malignant melanoma of the skin (excluding eyelid). En: Beahrs OH, Henson DE, Hutter RVP, y cols., eds. American Joint Committee on Cancer Manual for staging of cancer. 4th ed. Philladelphia: JB Lippincott 1992:143-8.
24. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:268-9.
25. Brossart P, Schmier J, Kruger S, y cols. A polymerase chain reaction-based semiquan titative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995; 55:4065-8.
26. Curry BJ, Smith J, Hersey P. Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 1996;6:45-54.
27. Pittman K, Burchill S, Smith B, y cols. Reverse transcriptase polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 1996;7:297-301.
28. Ghossein RA, Coit D, Brennan M, y cols. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 1998;4:419-28.
29. Kunter U, Buer J, Probst M, y cols. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996;88:590-4.
30. Reinhold U, Ludtke-Handjery HC, Schnautz S, y cols. The analysis of tyrosinase [specific RNAm in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 1997;108:166-9.
31. Schlupen E, Kunter U, Buer J, y cols. Peripheral blood tyrosinase RNAm detection and survival in malignant melanoma. Proceedings of XIII Jarestagung der Arbeitsgemeinschaft Dermatologische Forschung, p. 25.
32. Glaser R, Hauschild A, Lohmeier C, y cols. Determination of tyrosinase RNAm in peripheral blood is not a prognostic marker for progresive malignant melanoma. Proceedings of XIII Jarestagung der Arbeitsgemeinschaft Dermatologische Forschung, p. 26.
33. Hanekom GS, Johnson CA, Kidson SH. An improved and combined reverse tran scription-polymerase chain reaction assay for reliable detection of metasiatic melanoma cells in peripheral blood. Melanoma Res 1997;7:111-6.
34. Curry BJ, Myers K, Hersey P. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment and recurrence from melanoma. J Clin Oncol 1998;16:1760-9.
35. Eberle J, Garbe C, Wang N, y cols. Incomplete expression of the tyrosinase gene family (Tyrosinase, TRP-1 and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 1995;8:307-13.